Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia in a Pediatric Patient After COVID-19 Infection Complicated by MIS-C

The COVID-19 pandemic has impacted the care of countless individuals, including pediatric oncology patients. The initial lack of knowledge about the disease course and implications of infection led to delays in treatment to minimize additional harm. In pediatric oncology, unnecessary delays in chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Kayleigh M., Honstain, Chelsea, Spruit, Jessica L., Harris, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801970/
https://www.ncbi.nlm.nih.gov/pubmed/35256228
http://dx.doi.org/10.1016/j.pedhc.2022.01.006
_version_ 1784642572124160000
author Schwartz, Kayleigh M.
Honstain, Chelsea
Spruit, Jessica L.
Harris, Megan
author_facet Schwartz, Kayleigh M.
Honstain, Chelsea
Spruit, Jessica L.
Harris, Megan
author_sort Schwartz, Kayleigh M.
collection PubMed
description The COVID-19 pandemic has impacted the care of countless individuals, including pediatric oncology patients. The initial lack of knowledge about the disease course and implications of infection led to delays in treatment to minimize additional harm. In pediatric oncology, unnecessary delays in chemotherapy or hematopoietic stem cell transplantation may increase the risk of disease relapse. This case report describes one high-risk pediatric oncology patient's clinical course through hematopoietic stem cell transplantation immediately following COVID-19 infection complicated by multisystem inflammatory syndrome in children. The disease course, monitoring, long-term outcome, and recommendations for future research are reviewed.
format Online
Article
Text
id pubmed-8801970
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88019702022-01-31 Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia in a Pediatric Patient After COVID-19 Infection Complicated by MIS-C Schwartz, Kayleigh M. Honstain, Chelsea Spruit, Jessica L. Harris, Megan J Pediatr Health Care Case Report The COVID-19 pandemic has impacted the care of countless individuals, including pediatric oncology patients. The initial lack of knowledge about the disease course and implications of infection led to delays in treatment to minimize additional harm. In pediatric oncology, unnecessary delays in chemotherapy or hematopoietic stem cell transplantation may increase the risk of disease relapse. This case report describes one high-risk pediatric oncology patient's clinical course through hematopoietic stem cell transplantation immediately following COVID-19 infection complicated by multisystem inflammatory syndrome in children. The disease course, monitoring, long-term outcome, and recommendations for future research are reviewed. by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. 2022 2022-01-31 /pmc/articles/PMC8801970/ /pubmed/35256228 http://dx.doi.org/10.1016/j.pedhc.2022.01.006 Text en Copyright © 2022 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Case Report
Schwartz, Kayleigh M.
Honstain, Chelsea
Spruit, Jessica L.
Harris, Megan
Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia in a Pediatric Patient After COVID-19 Infection Complicated by MIS-C
title Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia in a Pediatric Patient After COVID-19 Infection Complicated by MIS-C
title_full Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia in a Pediatric Patient After COVID-19 Infection Complicated by MIS-C
title_fullStr Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia in a Pediatric Patient After COVID-19 Infection Complicated by MIS-C
title_full_unstemmed Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia in a Pediatric Patient After COVID-19 Infection Complicated by MIS-C
title_short Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia in a Pediatric Patient After COVID-19 Infection Complicated by MIS-C
title_sort allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia in a pediatric patient after covid-19 infection complicated by mis-c
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801970/
https://www.ncbi.nlm.nih.gov/pubmed/35256228
http://dx.doi.org/10.1016/j.pedhc.2022.01.006
work_keys_str_mv AT schwartzkayleighm allogeneichematopoieticstemcelltransplantforacutelymphoblasticleukemiainapediatricpatientaftercovid19infectioncomplicatedbymisc
AT honstainchelsea allogeneichematopoieticstemcelltransplantforacutelymphoblasticleukemiainapediatricpatientaftercovid19infectioncomplicatedbymisc
AT spruitjessical allogeneichematopoieticstemcelltransplantforacutelymphoblasticleukemiainapediatricpatientaftercovid19infectioncomplicatedbymisc
AT harrismegan allogeneichematopoieticstemcelltransplantforacutelymphoblasticleukemiainapediatricpatientaftercovid19infectioncomplicatedbymisc

Ejemplares similares